FTC moves to block Amgen's $27.8 billion deal for horizon therapeutics: Report
The US Federal Trade Commission (FTC) is expected to file a lawsuit as early as Tuesday to block Amgen Inc's AMGN.O $27.8 billion deal to buy Horizon Therapeutics PLC HZNP.O, a person familiar with the matter.